Managers

Phil Inc scores $25 mln Series B

San Francisco-based Phil Inc, a technology platform for distributing and managing specialty prescription drugs, has raised $25 million in Series B funding. GreatPoint Ventures led the round with participation from Tarsadia Investments, Crosslink Capital and Uncork Capital.

Solera Health inks $42 mln Series C

Phoenix-based Solera Health, a health network, has secured $42 million in Series C funding. HCSC Ventures led the round.

Solera Health inks $42 mln Series C

Phoenix-based Solera Health, a health network, has secured $42 million in Series C funding. HCSC Ventures led the round.

Phathom Pharmaceuticals grabs $90 mln

Menlo Park, California-based Phathom Pharmaceuticals, a newly launched biopharmaceutical company focused on treating gastrointestinal diseases and disorders, has secured $90 million in funding. Frazier Healthcare Partners led the round with participation from other investors that included Medicxi, RA Capital Management, Abingworth, certain accounts managed by Janus Henderson Investors, BVF Partners LP, Greenspring Associates, Richard King Mellon Foundation and Sahsen. Also, Phathom has secured a $50 million term loan facility from Silicon Valley Bank.

Phathom Pharmaceuticals grabs $90 mln

Menlo Park, California-based Phathom Pharmaceuticals, a newly launched biopharmaceutical company focused on treating gastrointestinal diseases and disorders, has secured $90 million in funding. Frazier Healthcare Partners led the round with participation from other investors that included Medicxi, RA Capital Management, Abingworth, certain accounts managed by Janus Henderson Investors, BVF Partners LP, Greenspring Associates, Richard King Mellon Foundation and Sahsen. Also, Phathom has secured a $50 million term loan facility from Silicon Valley Bank.

Chaifetz Group of Chicago looks to keep investments close to home

Ex-Shepherd GP's Cure8 Ventures raises $2.6 mln toward VC fund

Cure8 Ventures has raised $2.6 million toward a venture-capital fund, according to a filing with the SEC.

Ex-Shepherd GP's Cure8 Ventures raises $2.6 mln toward VC fund

Cure8 Ventures has raised $2.6 million toward a venture-capital fund, according to a filing with the SEC.

IsoPlexis rallies $25 mln Series C

Branford, Connecticut-based IsoPlexis, a biotechnology company, has raised $25 million in Series C funding. Northpond Ventures led the round.

IsoPlexis rallies $25 mln Series C

Branford, Connecticut-based IsoPlexis, a biotechnology company, has raised $25 million in Series C funding. Northpond Ventures led the round.